Related Experiment Video
Updated: Jun 1, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
Tolga Acun1, Emin Oztas, Tamer Yagci
1Bilkent University, Department of Molecular Biology and Genetics, Ankara, Turkey.
Background:
Smad interacting protein-1 is a transcription factor that is implicated in transforming growth factor-β/bone morphogenetic protein signaling and a repressor of E-cadherin and human telomerase reverse transcriptase. It is also involved in epithelial-mesenchymal transition and tumorigenesis. However, genetic and epigenetic alterations of SIP1 have not been fully elucidated in cancers. In this study, we investigated mutations and promoter hypermethylation of the SIP1 gene in human hepatocellular carcinomas.
Methods:
SIP1 expression was analyzed in HCC cell lines and primary tumors in comparison to normal and non-tumor liver tissues by using semi-quantitative RT-PCR, quantitative real-time RT-PCR and immunohistochemistry. Mutation and deletion screening of the SIP1 gene were performed by direct sequencing in HCC-derived cells. Restoration of SIP1 expression was sought by treating HCC cell lines with the DNA methyl transferase inhibitor, 5-AzaC, and the histone deacetylase inhibitor, TSA. SIP1 promoter methylation was analyzed by the combined bisulfite restriction analysis assay in in silico-predicted putative promoter and CpG island regions.
Results:
We found that the expression of SIP1 was completely lost or reduced in five of 14 (36%) HCC cell lines and 17 of 23 (74%) primary HCC tumors. Immunohistochemical analysis confirmed that SIP1 mRNA downregulation was associated with decreased expression of the SIP1 protein in HCC tissues (82.8%). No somatic mutation was observed in SIP1 exons in any of the 14 HCC cell lines. Combined treatment with DNA methyl transferase and histone deacetylase inhibitors synergistically restored SIP1 expression in SIP1-negative cell lines. Analysis of three putative gene regulatory regions revealed tumor-specific methylation in more than half of the HCC cases.
Conclusions:
Epigenetic mechanisms contribute significantly to the downregulation of SIP1 expression in HCC. This finding adds a new level of complexity to the role of SIP1 in hepatocarcinogenesis.
Insights
Epigenetic silencing of Smad interacting protein-1 (SIP1) significantly reduces its expression in hepatocellular carcinoma (HCC). This downregulation, driven by promoter hypermethylation, contributes to liver cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Smad interacting protein-1 (SIP1) is a transcription factor involved in TGF-β signaling, cell adhesion, and tumorigenesis.
- Genetic and epigenetic alterations of SIP1 in cancer remain incompletely understood.
- SIP1 plays a role in epithelial-mesenchymal transition and tumor progression.
Purpose of the Study:
- To investigate mutations and promoter hypermethylation of the SIP1 gene in human hepatocellular carcinomas (HCC).
- To elucidate the mechanisms underlying SIP1 downregulation in liver cancer.
Main Methods:
- Analyzed SIP1 expression in HCC cell lines and primary tumors using RT-PCR and immunohistochemistry.
- Screened for SIP1 gene mutations via direct sequencing.
- Investigated SIP1 promoter methylation using combined bisulfite restriction analysis.
- Assessed SIP1 expression restoration with DNA methyl transferase and histone deacetylase inhibitors.
Main Results:
- SIP1 expression was lost or reduced in 36% of HCC cell lines and 74% of primary HCC tumors.
- Downregulation of SIP1 mRNA correlated with decreased SIP1 protein expression in HCC tissues.
- No somatic mutations were found in SIP1 exons.
- Tumor-specific methylation was detected in SIP1 regulatory regions in over half of HCC cases.
- Combined epigenetic inhibitor treatment restored SIP1 expression in SIP1-negative cell lines.
Conclusions:
- Epigenetic mechanisms, particularly promoter hypermethylation, significantly contribute to SIP1 downregulation in HCC.
- This epigenetic silencing of SIP1 adds complexity to its role in hepatocarcinogenesis.
- Targeting epigenetic modifications may offer therapeutic strategies for HCC.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Cell Specific Gene Expression
Induced Pluripotent Stem Cells
Somatic cells are...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
